Physician profile
Vivek Vanmala Kumar
NPI 1508814906
$12,670.18
in general payments reported to CMS, 2019-2025
43 companies · $3,787 in 2025
The $3,787 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $693 · 2021: $963 · 2022: $1,658 · 2023: $2,629 · 2024: $1,380 · 2025: $3,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,914 · Travel and Lodging: $1,783 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,914.04 |
| Travel and Lodging | $1,782.65 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,062.18 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $2,049.22 | 2019-2025 | Ingevity Mri, Ingevity+, General - Brady |
| Abbott Laboratories | $1,397.33 | 2019-2025 | Aveir, Ensite Precision, Jot Dx |
| Actelion Pharmaceuticals US, INC. | $684.50 | 2019-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $624.05 | 2019-2025 | |
| Amgen INC. | $560.12 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $545.36 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Hawkone |
| Reflow Medical INC | $308.61 | 2024-2025 | |
| Pfizer INC. | $307.15 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $292.34 | 2019-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $286.91 | 2022-2025 | Verquvo, Winrevair |
| Stryker Corporation | $280.12 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Janssen Pharmaceuticals, INC | $244.35 | 2019-2023 | Xarelto |
| Philips North America LLC | $231.89 | 2020-2025 | (Ck7) Extended Holter, Event, Extended Holter |
| Biotronik INC. | $221.05 | 2019-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $215.13 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $198.96 | 2022-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $196.46 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.35 | 2019-2025 | Jardiance |
| Cardiovascular Systems INC. | $193.33 | 2019-2023 | Diamondback Coronary |
| Penumbra, INC. | $175.61 | 2019-2025 | Indigo System, Penumbra System |
| Medtronic Vascular, INC. | $156.14 | 2019-2020 | |
| Cvrx, INC. | $148.51 | 2021-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $138.29 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.47 | 2019-2022 | |
| Cardinal Health 200 LLC | $120.24 | 2019 | |
| Kestra Medical Technology Services, INC. | $78.55 | 2023-2024 | Assure Wcd |
| Scpharmaceuticals INC. | $71.94 | 2024-2025 | |
| Gilead Sciences, INC. | $71.81 | 2019-2020 | |
| Angiodynamics, INC. | $68.50 | 2022-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| United Therapeutics Corporation | $47.19 | 2019-2023 | Tyvaso |
| Bridgebio Pharma, INC. | $46.77 | 2025 | Attruby |
| Astellas Pharma US INC | $46.26 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $41.56 | 2019 | |
| Abiomed | $40.33 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $35.71 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $29.20 | 2021 | |
| Vital Connect, INC | $27.49 | 2023 | Vitalpatch Rtm |
| Heartflow, INC. | $27.21 | 2025 | |
| Ekos Corporation | $22.31 | 2019 | |
| Amarin Pharma, INC. | $21.32 | 2022 | |
| Glaxosmithkline, LLC. | $14.01 | 2025 | Shingrix, Arexvy |
| Kowa Pharmaceuticals America, INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.